Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

NCT02648854 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T
DRUG: CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T

Sponsor

Chong Kun Dang Pharmaceutical